Simi Valley not worried about AeroVironment’s headquarters move
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Home prices skyrocket in region
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Biotech’s movers and shakers gather for BioMedley
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Scenes from the reopening: lottery winners, maskless customers
The doors of the region’s businesses were fully open on June 15 for the first time in 15 months — and two Central Coast residents became millionaires — as California lifted nearly all of its COVID-19 restrictions. The state appears to have the upper hand on the virus, with new cases down to around 1,000 Read More →
AeroVironment moves headquarters out of Simi Valley
Fifty years after it was founded and two and a half after it moved to Simi Valley, the drone developer and manufacturer AeroVironment is moving its headquarters to Arlington, Virginia, effective immediately. The company made the announcement with an early morning news release on June 15. “The greater Washington D.C. area is where many of Read More →
Festivals and fairs plan summer comeback
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s new drug could be a blockbuster
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
